Login / Signup

Induction of labour at 41 weeks or expectant management until 42 weeks: A systematic review and an individual participant data meta-analysis of randomised trials.

Mårten AlkmarkJudit K J KeulenJoep C KortekaasChristina BerghJeroen van DillenRuben G DuijnhovenHenrik HagbergBen-Willem J MolMattias MolinJoris A M Van Der PostSissel SaltvedtAnna-Karin WikströmUlla-Britt WennerholmEsteriek De Miranda
Published in: PLoS medicine (2020)
In this study, we found that, overall, IOL at 41 weeks improved perinatal outcome compared with expectant management until 42 weeks without increasing the cesarean delivery rate. This benefit is shown only in nulliparous women, whereas for multiparous women, the incidence of mortality and morbidity was too low to demonstrate any effect. The magnitude of risk reduction of perinatal mortality remains uncertain. Women with pregnancies approaching 41 weeks should be informed on the risk differences according to parity so that they are able to make an informed choice for IOL at 41 weeks or expectant management until 42 weeks. Study Registration: PROSPERO CRD42020163174.
Keyphrases
  • gestational age
  • clinical trial
  • pregnant women
  • polycystic ovary syndrome
  • risk factors
  • pregnancy outcomes
  • randomized controlled trial
  • machine learning
  • cardiovascular disease
  • cervical cancer screening